Physician Quick Search
By Name:
By Specialty:
Radiation Oncology
The Department of Radiation Oncology at Washington University is dedicated to excellence in patient care, teaching and research. The department is one of the largest in the United States and a national leader in developing the most recent radiation treatments for cancer patients. Our physicians are committed to patients in all aspects of care
Your Healthy Update

Like us on Facebook
Text Size: S M L
Search

Radiation Oncology

Wade Larry Thorstad, MD

Current Position
Assistant Professor, Radiation Oncology
Chief, Head and Neck Cancer Service


Specialty Areas
Head and Neck Oncology
Gastrointestinal Oncology
Nuclear Medicine
Radiation Oncology
Thoracic Oncology

Additional Features & Interviews with Dr. Thorstad:



Featured Physician

Patients Seen At
Siteman Cancer Center
Center for Advanced Medicine
4921 Parkview Place, Lower Level, LL
St. Louis, MO  63110
314-747-7236
314-747-9600
Fax:   314-362-7769
View Floor Map  View Campus Map   View Driving Directions

Mailing Address
Washington University School of Medicine
Department of Radiation Oncology
660 South Euclid Avenue, Campus Box 8224
St. Louis, MO  63110

Areas of Clinical Interest
Head and neck oncology, thoracic cancer, tumors, systemic radiotherapy, radioimmunotherapy, radioimmunodiagnosis, nuclear oncology, PET

Board Certification
Radiation Oncology -- Certified
Nuclear Medicine -- Certified

Medical Education
B.A.: Trinity University, San Antonio, Texas, 1986
Medical Degree: University of Texas Medical School, Houston, Texas, 1991
Residency: Radiation Oncology, Loyola University Medical Center, Chicago, Illinois, 1995
Residency: Nuclear Medicine, Duke University Medical Center, Durham, North Carolina, 1997
Fellowship: Radiation Oncology, Mayo Clinic, Rochester, Minnesota, 1998
Hospital Affiliations
Barnes-Jewish Hospital

Honors and Awards
Listed in Best Doctors in America, 2011-2013 (Best Doctors, Inc.)

Selected Recent Journal Articles
Rich JT, Milov S, Lewis JS Jr, Thorstad WL, Adkins DR, Haughey BH.Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors.Laryngoscope. 2009 Sep;119(9):1709-19.

Li H, Thorstad WL, Biehl KJ, Laforest R, Su Y, Shoghi KI, Donnelly ED, Low DA, Lu W.
A novel PET tumor delineation method based on adaptive region-growing and dual-front active contours. Cardiovasc Interv 2003; 59(2):251-254 Med Phys. 2008 Aug;35(8):3711-21.

Engel SH, Hullar TE, Adkins DR, Thorstad WL, Sunwoo JB.Temporal relationship between antitumor necrosis factor-alpha antibody therapy and recrudescence of head and neck squamous cell carcinoma. Laryngoscope. 2008 Mar;118(3):450-2.

Wilkens JJ, Alaly JR, Zakarian K, Thorstad WL, Deasy JO. IMRT treatment planning based on prioritizing prescription goals. Phys Med Biol. 2007 Mar 21;52(6):1675-92. Epub 2007 Feb 27

Lin LL, Picus J, Drebin JA, Linehan DC, Solis J, Strasberg SM, Tan B, Thorstad WL, Myerson R.A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma. Am J Clin Oncol. 2005 Jun;28(3):234-41.

Thorstad WL, Chao KS, Haughey B. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
Semin Oncol. 2004 Dec;31(6 Suppl 18):8-12.

Bradley J, Thorstad WL, Mutic S, Miller TR, Dehdashti F, Siegel BA, Bosch W, Bertrand RJ.Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):78-86.

Blanco AI, Chao KS, Ozyigit G, Adli M, Thorstad WL, Simpson JR, Spector GJ, Haughey B, Perez CA.Carcinoma of paranasal sinuses: long-term outcomes with radiotherapy. Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):51-8.

Paulino AC, Thorstad WL, Fox T. Role of fusion in radiotherapy treatment planning. Semin Nucl Med 2003; 33(3):238-243

Marriott CJ, Thorstad W, Akabani G, Brown MT, McLendon RE, Hanson MW, Coleman RE. Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors. J Nucl Med 1998; 39(8):1376-80

Bigner DD, Brown MT, Friedman AH, Coleman RE, Akabani G, Friedman HS, Thorstad WL, McLendon RE, Bigner SH, Zhao X-G, Pegram CN, Wikstrand CJ, Herndon II JE, Vick NA, Paleologos N, Cokgor I, Provenzale JM, Zalutsky MR. Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: Phase I trial results. J Clin Oncol 1998, 16(6):2202-2212

For more articles and abstracts, take this off-site link to the National Library of Medicine Pub Med page for Dr. Thorstad

Washington University Physicians are the medical staff of  Barnes-Jewish Hospital and Children's Hospital - St. Louis Employment   About Us   Top Stories   For Your Protection      Site Map
Copyright 2014 Washington University School of Medicine
Copyright 2014 Washington University School of Medicine